CleanTech (NASDAQ:CLAQ) disclosed this afternoon that its shareholders approved its combination with subsea robot company Nauticus at a special meeting held earlier today.
But, the 8-K filing also disclosed that stockholders holding 361,986 shares of common stock exercised their right to redeem for a portion of the funds in CLAQ’s trust account. As a result, a total of 91.761% has been removed from CLAQ’s trust to-date, which includes previous redemption vote figures, to pay such stockholders.
At the meeting, a total of 4,510,569 shares of CLAQ common stock, representing approximately 73.99% of the issued and outstanding shares of common stock, were present. The business combination was overwhelmingly approved with 4,505,113 shares in favor of the transaction and just 5,456 against it.
The CleanTech deal was supplemented by a $73 million PIPE. The PIPE drew investment from strategic investment from Schlumberger (NYSE:SLB), Transocean (NYSE:RIG) and AeroVironment (NASDAQ:AVAV). CleanTech had to maintain at least $50 million in cash in order for the deal to close.
The parties did not disclose the exact timeline for the deal, but it is expected to close shortly and trade on the Nasdaq under the symbol “KITT”.
CleanTech initially announced the $377 million combination with Nauticus on December 17. The Houston, Texas-based company provides undersea robotics platforms for maintenance, security and other tasks.
ADVISORS
- Chardan acted as exclusive financial advisor to CLAQ and as sole placement agent on the PIPE.
- Loeb & Loeb LLP acted as the legal advisor to CLAQ.
- Winston & Strawn LLP acted as the legal advisor to Nauticus.
Perimeter Acquisition Corp. I (NASDAQ:PMTRU) announced the pricing of its upsized $210 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “PMTRU”, Tuesday, May 13, 2025. The new SPAC aims to combine with a target company with that can contribute to the re-industrialization of the United States economy,...
Horizon Space II (NASDAQ:HSPT) has signed a definitive agreement to combine with clinical stage biotech firm SL Bio Ltd. for $5.57 billion in equity consideration. Taipei, Taiwan-based SL Bio is developing drug candidates to treat several cancer types while also selling over-the-counter beauty products derived from natural extracts. The combined company is expected to trade...
At the SPAC of Dawn This is set to be a slower week for votes with just two SPACs seeking an extension and none yet scheduling a meeting for approving a business combination. Integrated Rail & Resources (OTC:IRRX) primed the pump somewhat for investors ahead of its Tuesday special meeting by announcing it has entered...
Terms Tracker for the Week Ending May 9, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. After the sprint that was last week, with nine IPOs and six new SPAC filings, this week took a breather. Only two SPACs priced, there...
Lake Superior (NASDAQ:LKSPU) has filed for a $100 million SPAC as its CEO attempts to go three-for-three with SPACs that led to completed deals. This new vehicle has one right to a 1/6 share in each unit and some common features of a SPAC underwritten by Cohen & Company in this current climate. Although the...